1. Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates. Issue 42 (9th October 2017) Authors: Kroiss, Steve J.; Famulare, Michael; Lyons, Hil; McCarthy, Kevin A.; Mercer, Laina D.; Chabot-Couture, Guillaume Journal: Vaccine Issue: Volume 35:Issue 42(2017) Page Start: 5674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Feature-level analysis of a novel smartphone application for smoking cessation. (January 2015) Authors: Heffner, Jaimee L.; Vilardaga, Roger; Mercer, Laina D.; Kientz, Julie A.; Bricker, Jonathan B. Journal: American journal of drug and alcohol abuse Issue: Volume 41:Number 1(2015:Jan.) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of state weights on national vaccination coverage estimates from household surveys in Nigeria. Issue 32 (6th July 2020) Authors: Dong, Tracy Qi; Rhoda, Dale A.; Mercer, Laina D. Journal: Vaccine Issue: Volume 38:Issue 32(2020) Page Start: 5060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition. Issue 4 (23rd January 2023) Authors: Rennert, Wolfgang; Hindiyeh, Musa; Allahham, Majd; Mercer, Laina D.; Hamad, Khalil I.; Ghuneim, Nedal I.; A. M. Eljaro, Zuheir; Abu-Awwad, Fakhr; Bozya, Yaser; Hjaija, Diaa; Bhat, Niranjan; Leader, Troy; Ramlawi, Asad; Marzouqa, Hiyam Journal: Vaccine Issue: Volume 41:Issue 4(2023) Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam. Issue 26 (9th June 2022) Authors: Duc Dang, Anh; Dinh Vu, Thiem; Hai Vu, Ha; Thanh Ta, Van; Thi Van Pham, Anh; Thi Ngoc Dang, Mai; Van Le, Be; Huu Duong, Thai; Van Nguyen, Duoc; Lawpoolsri, Saranath; Chinwangso, Pailinrut; McLellan, Jason S.; Hsieh, Ching-Lin; Garcia-Sastre, Adolfo; Palese, Peter; Sun, Weina; Martinez, Jose L.; G... Journal: Vaccine Issue: Volume 40:Issue 26(2022) Page Start: 3621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial. (March 2022) Authors: Pitisuttithum, Punnee; Luvira, Viravarn; Lawpoolsri, Saranath; Muangnoicharoen, Sant; Kamolratanakul, Supitcha; Sivakorn, Chaisith; Narakorn, Piengthong; Surichan, Somchaiya; Prangpratanporn, Sumalee; Puksuriwong, Suttida; Lamola, Steven; Mercer, Laina D.; Raghunandan, Rama; Sun, Weina; Liu, Yong... Journal: EClinicalMedicine Issue: Volume 45(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Issue 10 (3rd March 2023) Authors: Erdem, Rahsan; De Coster, Ilse; Withanage, Kanchanamala; Mercer, Laina D.; Marchant, Arnaud; Taton, Martin; Cools, Nathalie; Lion, Eva; Cassels, Fred; Higgins, Deborah; Ivinson, Karen; Locke, Emily; Mahmood, Kutub; Wright, Peter F.; Gast, Chris; White, Jessica A.; Ackerman, Margaret E.; Konopka-A... Journal: Vaccine Issue: Volume 41:Issue 10(2023) Page Start: 1657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗